Header Logo

Connection

BARBARA JANE O'BRIEN to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications BARBARA JANE O'BRIEN has written about Dose-Response Relationship, Drug.
BARBARA JANE O'BRIEN
Connection Strength
0.019
Dose-Response Relationship, Drug
  1. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol. 2016 09; 129(3):487-494.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.